BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,774 | -17.2% | 100,000 | 0.0% | 1.08% | -15.4% |
| Q2 2023 | $4,556 | +12.3% | 100,000 | 0.0% | 1.28% | +16.4% |
| Q1 2023 | $4,056 | -20.5% | 100,000 | -0.3% | 1.10% | -21.3% |
| Q4 2022 | $5,103 | -99.9% | 100,300 | +43.3% | 1.40% | +24.1% |
| Q3 2022 | $3,770,000 | -16.1% | 70,000 | 0.0% | 1.12% | -14.1% |
| Q2 2022 | $4,496,000 | -17.2% | 70,000 | 0.0% | 1.31% | -12.2% |
| Q1 2022 | $5,428,000 | -9.7% | 70,000 | 0.0% | 1.49% | -15.3% |
| Q4 2021 | $6,009,000 | +6.7% | 70,000 | 0.0% | 1.76% | -8.0% |
| Q3 2021 | $5,630,000 | -0.1% | 70,000 | 0.0% | 1.91% | -3.6% |
| Q2 2021 | $5,635,000 | -4.6% | 70,000 | 0.0% | 1.98% | -12.2% |
| Q1 2021 | $5,904,000 | +5.1% | 70,000 | 0.0% | 2.26% | -3.7% |
| Q4 2020 | $5,617,000 | -0.2% | 70,000 | 0.0% | 2.34% | +3.8% |
| Q3 2020 | $5,629,000 | -7.1% | 70,000 | -30.0% | 2.26% | -5.3% |
| Q2 2020 | $6,056,000 | +6.6% | 100,000 | +42.9% | 2.39% | +8.8% |
| Q1 2020 | $5,683,000 | -2.9% | 70,000 | 0.0% | 2.19% | +5.1% |
| Q4 2019 | $5,853,000 | -4.4% | 70,000 | 0.0% | 2.09% | -3.7% |
| Q3 2019 | $6,123,000 | +6.8% | 70,000 | 0.0% | 2.17% | +14.9% |
| Q2 2019 | $5,733,000 | +0.7% | 70,000 | 0.0% | 1.89% | -2.5% |
| Q1 2019 | $5,692,000 | +23.6% | 70,000 | 0.0% | 1.94% | +13.5% |
| Q4 2018 | $4,607,000 | -14.6% | 70,000 | 0.0% | 1.70% | +1.7% |
| Q3 2018 | $5,396,000 | +4.4% | 70,000 | 0.0% | 1.68% | -1.8% |
| Q2 2018 | $5,169,000 | +13.5% | 70,000 | 0.0% | 1.71% | +6.8% |
| Q1 2018 | $4,553,000 | +0.6% | 70,000 | 0.0% | 1.60% | -0.7% |
| Q4 2017 | $4,525,000 | +3.0% | 70,000 | 0.0% | 1.61% | +5.0% |
| Q3 2017 | $4,393,000 | +3.7% | 70,000 | 0.0% | 1.53% | -1.3% |
| Q2 2017 | $4,238,000 | +16.7% | 70,000 | 0.0% | 1.55% | +23.8% |
| Q1 2017 | $3,630,000 | +16.9% | 70,000 | 0.0% | 1.26% | +14.1% |
| Q4 2016 | $3,104,000 | -6.8% | 70,000 | 0.0% | 1.10% | +4.1% |
| Q3 2016 | $3,332,000 | +5.3% | 70,000 | 0.0% | 1.06% | +1.4% |
| Q2 2016 | $3,165,000 | +10.0% | 70,000 | 0.0% | 1.04% | +3.5% |
| Q1 2016 | $2,876,000 | +25.0% | 70,000 | 0.0% | 1.01% | +15.9% |
| Q3 2015 | $2,300,000 | -53.1% | 70,000 | -18.6% | 0.87% | -47.9% |
| Q2 2015 | $4,906,000 | -48.9% | 86,000 | -38.6% | 1.67% | +5.2% |
| Q1 2015 | $9,607,000 | +87.3% | 140,000 | +100.0% | 1.59% | -8.1% |
| Q4 2014 | $5,130,000 | +2.1% | 70,000 | 0.0% | 1.73% | +8.3% |
| Q3 2014 | $5,024,000 | -2.5% | 70,000 | 0.0% | 1.59% | -4.3% |
| Q1 2014 | $5,151,000 | +12.0% | 70,000 | -30.0% | 1.66% | +9.0% |
| Q3 2013 | $4,600,000 | -5.1% | 100,000 | +42.9% | 1.53% | -11.5% |
| Q2 2013 | $4,849,000 | – | 70,000 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |